KNBIF
Price:
$0.06735
Market Cap:
$13.75M
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorpo...[Read more]
Industry
Biotechnology
IPO Date
2007-08-07
Stock Exchange
PNK
Ticker
KNBIF
According to Kane Biotech Inc.’s latest financial reports and current stock price. The company's current ROE is -94.49%. This represents a change of -67.35% compared to the average of -289.37% of the last 4 quarters.
The mean historical ROE of Kane Biotech Inc. over the last ten years is -7.72%. The current -94.49% ROE has changed 1.12% with respect to the historical average. Over the past ten years (40 quarters), KNBIF's ROE was at its highest in in the June 2019 quarter at 3.70%. The ROE was at its lowest in in the June 2024 quarter at -1272.35%.
Average
-7.72%
Median
-27.04%
Minimum
-356.07%
Maximum
331.12%
Discovering the peaks and valleys of Kane Biotech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 192.13%
Maximum Annual ROE = 331.12%
Minimum Annual Increase = -425.40%
Minimum Annual ROE = -356.07%
Year | ROE | Change |
---|---|---|
2023 | 47.68% | -20.05% |
2022 | 59.64% | -49.67% |
2021 | 118.49% | -52.51% |
2020 | 249.51% | -317.45% |
2019 | -114.74% | -134.65% |
2018 | 331.12% | -425.40% |
2017 | -101.76% | -46.20% |
2016 | -189.15% | -46.88% |
2015 | -356.07% | 192.13% |
2014 | -121.89% | 8.06% |
The current ROE of Kane Biotech Inc. (KNBIF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
75.27%
5-year avg
72.12%
10-year avg
-7.72%
Kane Biotech Inc.’s ROE is less than Neurobiological Technologies, Inc. (0%), greater than Pharming Group N.V. (-8.08%), less than Health Sciences Group, Inc. (0%), less than MedMira Inc. (19.92%), greater than Oxford Cannabinoid Technologies Holdings Plc (-86.76%),
Company | ROE | Market cap |
---|---|---|
0% | $2.70K | |
-8.08% | $651.22M | |
0% | $187.09K | |
19.92% | $41.40M | |
-86.76% | $3.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kane Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kane Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Kane Biotech Inc.'s ROE?
How is the ROE calculated for Kane Biotech Inc. (KNBIF)?
What is the highest ROE for Kane Biotech Inc. (KNBIF)?
What is the 3-year average ROE for Kane Biotech Inc. (KNBIF)?
What is the 5-year average ROE for Kane Biotech Inc. (KNBIF)?
How does the current ROE for Kane Biotech Inc. (KNBIF) compare to its historical average?